GPT and fatty liver disease: After a completed 24-week follow-up, patients in both intervention and control groups experienced a significant reduction in weight, BMI, ALT level, liver steatosis by CAP measurement, and fat mass by BIA compared to their respective levels at baseline (within group analysis).